These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8059714)

  • 41. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
    Puri N; Dellinger RP
    Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
    Badalian SS; Silverman RK; Aubry RH; Longo J
    J Reprod Med; 2000 Feb; 45(2):149-52. PubMed ID: 10710749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
    Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
    Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhalation of nitric oxide. An innovative therapy for treatment of increased pulmonary vascular resistance.
    Rykerson S; Thompson J; Wessel DL
    Nurs Clin North Am; 1995 Jun; 30(2):381-90. PubMed ID: 7777413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hilgendorff A; Apitz C; Bonnet D; Hansmann G
    Heart; 2016 May; 102 Suppl 2():ii49-56. PubMed ID: 27053698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnesium sulfate to facilitate weaning of nitric oxide in pulmonary hypertension.
    al-Halees Z; Afrane B; el-Barbary M
    Ann Thorac Surg; 1997 Jan; 63(1):298-9. PubMed ID: 8993304
    [No Abstract]   [Full Text] [Related]  

  • 50. Pulmonary arterial hypertension in children.
    Rosenzweig EB; Widlitz AC; Barst RJ
    Pediatr Pulmonol; 2004 Jul; 38(1):2-22. PubMed ID: 15170869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects.
    Haydar A; Malhere T; Mauriat P; Journois D; Pouard P; Denis N; Lefèbvre D; Safran D; Vouhé P
    Lancet; 1992 Dec 19-26; 340(8834-8835):1545. PubMed ID: 1361626
    [No Abstract]   [Full Text] [Related]  

  • 52. Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension.
    Mahoney PD; Loh E; Blitz LR; Herrmann HC
    Am J Cardiol; 2001 Jan; 87(2):188-92. PubMed ID: 11152837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhaled nitric oxide therapy].
    Okamoto K; Kukita I; Koga T; Namihira T; Akiyama H
    Nihon Rinsho; 2001 Jun; 59(6):1126-31. PubMed ID: 11411124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of inhaled nitric oxide in treatment of neonatal pulmonary hypertension.
    Abman SH
    Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):542-5. PubMed ID: 10322917
    [No Abstract]   [Full Text] [Related]  

  • 56. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy.
    Goodwin TM; Gherman RB; Hameed A; Elkayam U
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):64-7. PubMed ID: 9914580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One-year continuous inhaled nitric oxide for primary pulmonary hypertension.
    Pérez-Peñate G; Julià-Serdà G; Pulido-Duque JM; Górriz-Gómez E; Cabrera-Navarro P
    Chest; 2001 Mar; 119(3):970-3. PubMed ID: 11243987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of pulmonary hypertension with inhaled nitric oxide during hepatic transplantation in an adolescent: reversibility of pulmonary hypertension after transplantation.
    Tarquino M; Geggel RL; Strauss RS; Rhodes J; Wunderlich B; Rohrer RJ
    Clin Pediatr (Phila); 1998 Aug; 37(8):505-9. PubMed ID: 9729707
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant.
    Sokol GM; Konduri GG; Van Meurs KP
    Semin Perinatol; 2016 Oct; 40(6):356-369. PubMed ID: 27480246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.
    Pepke-Zaba J; Higenbottam TW; Dinh-Xuan AT; Stone D; Wallwork J
    Lancet; 1991 Nov; 338(8776):1173-4. PubMed ID: 1682593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.